Five Virus Variants Fuel Second Wave of COVID-19 in Uganda 18/06/2021 Esther Nakkazi Uganda is suffering an acute shortage of oxygen and intensive care beds as the country grapples with a deadly second wave of the pandemic that is being fuelled by five different virus variants. Regional referral hospitals and the country’s biggest hospital, Mulago National Referral Hospital, have run out of oxygen or have reported acute shortages, […] Continue reading -> Guinea Poised to Declare End of Ebola Outbreak 17/06/2021 Paul Adepoju The government of Guinea is a few days away from declaring the end of the country’s Ebola outbreak after 45 days of reporting no new case, World Health Organization Officials said on Thursday. On 14 February, a new Ebola outbreak was declared in Guinea, but four months later, the outbreak will be declared over according […] Continue reading -> Tanzania Joins COVAX Vaccine Facility as Africa Enters Deadly COVID-19 Third Wave 17/06/2021 Paul Adepoju Tanzania, which for months denied the existence of COVID-19 until vaccine-sceptic President John Magufuli finally succumbed to the virus in March – is now trying to belatedly join the WHO co-sponsored COVAX facility to acquire COVID vaccines. The news comes as the African continent experiences a deadly third wave of COVID-19 infections – affecting eastern […] Continue reading -> Antibody Cocktail Reduces Risk of Death by 20% in Patients lacking Adequate SARS-CoV2 Immune Response 17/06/2021 Madeleine Hoecklin A COVID-19 antibody cocktail developed by the US-based company, Regeneron, dramatically reduced the risk of mortality and shortened hospital stays in patients who didn’t naturally produce antibodies against SARS-CoV2 in a recent large-scale trial. Meanwhile, the US government announced that it would invest some US$3.2 billion in developing new forms of antiviral COVID-19 treatments to […] Continue reading -> Latin America Plagued by Slow Vaccine Rollouts, While Region Remains Major COVID Epicenter 17/06/2021 Madeleine Hoecklin & Raisa Santos Despite the global decline in COVID-19 cases by 12% over the last week, countries in Central and South America continue to be epicenters of pandemic, with high mortality rates and insufficient access to vaccines. Over 1.1 million new COVID-19 cases and 31,000 deaths were reported in the Americas over the last week, officials from the […] Continue reading -> Pakistan Introduces Single-Use Syringes as it Battles Fast-Rising HIV/AIDS Infections 16/06/2021 Rahul Basharat Rajput & Muhammed Nadeem Chaudhry ISLAMABAD – Faced with one of the sharpest increases in HIV/AIDS rates in Asia, Pakistan will ban the manufacture and import of conventional syringes from next month, government officials have told Health Policy Watch. The move is in an effort to stem a three-year increase in HIV cases – 39% of which are estimated to […] Continue reading -> Groundbreaking Study: Mosquitoes Armed with Wolbachia Bacteria Reduced Symptomatic Dengue Infections by 77% In Indonesian Trial 16/06/2021 Madeleine Hoecklin In a “groundbreaking” trial conducted in Indonesia, lab-grown mosquitoes infected with Wolbachia bacteria reduced the rate of symptomatic dengue infections by 77%, and hospitalizations by 86%, in communities where the bacteria-armed mosquitoes were released. The three-year study, which was led by the World Mosquito Program, provides compelling evidence for a new method of controlling dengue. […] Continue reading -> Africa’s COVID-19 Vaccination Rollouts Falter as Third Wave Grips Parts of the Continent 15/06/2021 Kerry Cullinan Twenty-two African countries are experiencing a surge in COVID-19 infections, yet the vaccination rollouts on the continent have ground to a halt because of lack of supply. African vaccination figures, as recorded by the Africa Centers for Disease Control and Prevention, are dismal. Apart from the tiny island state of Seychelles, only Morocco’s vaccination rate […] Continue reading -> WHO to Study Social Measures That Keep COVID-19 at Bay – in Case of No Vaccines in Future Pandemics 14/06/2021 Kerry Cullinan The World Health Organization (WHO) is planning to study the public health and social measures that countries have used to keep COVID-19 at bay successfully – in case there is no quick vaccine for the next pandemic. A special working group has been set up with the support of Norway to study these measures, WHO […] Continue reading -> Novavax could make 100 million monthly doses of COVID-19 vaccine by October 14/06/2021 Paul Adepoju Biotech manufacturer Novavax announced on Monday it would be able to manufacture 100 million doses of its two-dose COVID-19 vaccine every month by the end of the third quarter of 2021 and 150 million doses per month by the end of the year – once it has secured regulatory approval for its vaccine. This follows […] Continue reading -> Posts navigation Older postsNewer posts
Guinea Poised to Declare End of Ebola Outbreak 17/06/2021 Paul Adepoju The government of Guinea is a few days away from declaring the end of the country’s Ebola outbreak after 45 days of reporting no new case, World Health Organization Officials said on Thursday. On 14 February, a new Ebola outbreak was declared in Guinea, but four months later, the outbreak will be declared over according […] Continue reading -> Tanzania Joins COVAX Vaccine Facility as Africa Enters Deadly COVID-19 Third Wave 17/06/2021 Paul Adepoju Tanzania, which for months denied the existence of COVID-19 until vaccine-sceptic President John Magufuli finally succumbed to the virus in March – is now trying to belatedly join the WHO co-sponsored COVAX facility to acquire COVID vaccines. The news comes as the African continent experiences a deadly third wave of COVID-19 infections – affecting eastern […] Continue reading -> Antibody Cocktail Reduces Risk of Death by 20% in Patients lacking Adequate SARS-CoV2 Immune Response 17/06/2021 Madeleine Hoecklin A COVID-19 antibody cocktail developed by the US-based company, Regeneron, dramatically reduced the risk of mortality and shortened hospital stays in patients who didn’t naturally produce antibodies against SARS-CoV2 in a recent large-scale trial. Meanwhile, the US government announced that it would invest some US$3.2 billion in developing new forms of antiviral COVID-19 treatments to […] Continue reading -> Latin America Plagued by Slow Vaccine Rollouts, While Region Remains Major COVID Epicenter 17/06/2021 Madeleine Hoecklin & Raisa Santos Despite the global decline in COVID-19 cases by 12% over the last week, countries in Central and South America continue to be epicenters of pandemic, with high mortality rates and insufficient access to vaccines. Over 1.1 million new COVID-19 cases and 31,000 deaths were reported in the Americas over the last week, officials from the […] Continue reading -> Pakistan Introduces Single-Use Syringes as it Battles Fast-Rising HIV/AIDS Infections 16/06/2021 Rahul Basharat Rajput & Muhammed Nadeem Chaudhry ISLAMABAD – Faced with one of the sharpest increases in HIV/AIDS rates in Asia, Pakistan will ban the manufacture and import of conventional syringes from next month, government officials have told Health Policy Watch. The move is in an effort to stem a three-year increase in HIV cases – 39% of which are estimated to […] Continue reading -> Groundbreaking Study: Mosquitoes Armed with Wolbachia Bacteria Reduced Symptomatic Dengue Infections by 77% In Indonesian Trial 16/06/2021 Madeleine Hoecklin In a “groundbreaking” trial conducted in Indonesia, lab-grown mosquitoes infected with Wolbachia bacteria reduced the rate of symptomatic dengue infections by 77%, and hospitalizations by 86%, in communities where the bacteria-armed mosquitoes were released. The three-year study, which was led by the World Mosquito Program, provides compelling evidence for a new method of controlling dengue. […] Continue reading -> Africa’s COVID-19 Vaccination Rollouts Falter as Third Wave Grips Parts of the Continent 15/06/2021 Kerry Cullinan Twenty-two African countries are experiencing a surge in COVID-19 infections, yet the vaccination rollouts on the continent have ground to a halt because of lack of supply. African vaccination figures, as recorded by the Africa Centers for Disease Control and Prevention, are dismal. Apart from the tiny island state of Seychelles, only Morocco’s vaccination rate […] Continue reading -> WHO to Study Social Measures That Keep COVID-19 at Bay – in Case of No Vaccines in Future Pandemics 14/06/2021 Kerry Cullinan The World Health Organization (WHO) is planning to study the public health and social measures that countries have used to keep COVID-19 at bay successfully – in case there is no quick vaccine for the next pandemic. A special working group has been set up with the support of Norway to study these measures, WHO […] Continue reading -> Novavax could make 100 million monthly doses of COVID-19 vaccine by October 14/06/2021 Paul Adepoju Biotech manufacturer Novavax announced on Monday it would be able to manufacture 100 million doses of its two-dose COVID-19 vaccine every month by the end of the third quarter of 2021 and 150 million doses per month by the end of the year – once it has secured regulatory approval for its vaccine. This follows […] Continue reading -> Posts navigation Older postsNewer posts
Tanzania Joins COVAX Vaccine Facility as Africa Enters Deadly COVID-19 Third Wave 17/06/2021 Paul Adepoju Tanzania, which for months denied the existence of COVID-19 until vaccine-sceptic President John Magufuli finally succumbed to the virus in March – is now trying to belatedly join the WHO co-sponsored COVAX facility to acquire COVID vaccines. The news comes as the African continent experiences a deadly third wave of COVID-19 infections – affecting eastern […] Continue reading -> Antibody Cocktail Reduces Risk of Death by 20% in Patients lacking Adequate SARS-CoV2 Immune Response 17/06/2021 Madeleine Hoecklin A COVID-19 antibody cocktail developed by the US-based company, Regeneron, dramatically reduced the risk of mortality and shortened hospital stays in patients who didn’t naturally produce antibodies against SARS-CoV2 in a recent large-scale trial. Meanwhile, the US government announced that it would invest some US$3.2 billion in developing new forms of antiviral COVID-19 treatments to […] Continue reading -> Latin America Plagued by Slow Vaccine Rollouts, While Region Remains Major COVID Epicenter 17/06/2021 Madeleine Hoecklin & Raisa Santos Despite the global decline in COVID-19 cases by 12% over the last week, countries in Central and South America continue to be epicenters of pandemic, with high mortality rates and insufficient access to vaccines. Over 1.1 million new COVID-19 cases and 31,000 deaths were reported in the Americas over the last week, officials from the […] Continue reading -> Pakistan Introduces Single-Use Syringes as it Battles Fast-Rising HIV/AIDS Infections 16/06/2021 Rahul Basharat Rajput & Muhammed Nadeem Chaudhry ISLAMABAD – Faced with one of the sharpest increases in HIV/AIDS rates in Asia, Pakistan will ban the manufacture and import of conventional syringes from next month, government officials have told Health Policy Watch. The move is in an effort to stem a three-year increase in HIV cases – 39% of which are estimated to […] Continue reading -> Groundbreaking Study: Mosquitoes Armed with Wolbachia Bacteria Reduced Symptomatic Dengue Infections by 77% In Indonesian Trial 16/06/2021 Madeleine Hoecklin In a “groundbreaking” trial conducted in Indonesia, lab-grown mosquitoes infected with Wolbachia bacteria reduced the rate of symptomatic dengue infections by 77%, and hospitalizations by 86%, in communities where the bacteria-armed mosquitoes were released. The three-year study, which was led by the World Mosquito Program, provides compelling evidence for a new method of controlling dengue. […] Continue reading -> Africa’s COVID-19 Vaccination Rollouts Falter as Third Wave Grips Parts of the Continent 15/06/2021 Kerry Cullinan Twenty-two African countries are experiencing a surge in COVID-19 infections, yet the vaccination rollouts on the continent have ground to a halt because of lack of supply. African vaccination figures, as recorded by the Africa Centers for Disease Control and Prevention, are dismal. Apart from the tiny island state of Seychelles, only Morocco’s vaccination rate […] Continue reading -> WHO to Study Social Measures That Keep COVID-19 at Bay – in Case of No Vaccines in Future Pandemics 14/06/2021 Kerry Cullinan The World Health Organization (WHO) is planning to study the public health and social measures that countries have used to keep COVID-19 at bay successfully – in case there is no quick vaccine for the next pandemic. A special working group has been set up with the support of Norway to study these measures, WHO […] Continue reading -> Novavax could make 100 million monthly doses of COVID-19 vaccine by October 14/06/2021 Paul Adepoju Biotech manufacturer Novavax announced on Monday it would be able to manufacture 100 million doses of its two-dose COVID-19 vaccine every month by the end of the third quarter of 2021 and 150 million doses per month by the end of the year – once it has secured regulatory approval for its vaccine. This follows […] Continue reading -> Posts navigation Older postsNewer posts
Antibody Cocktail Reduces Risk of Death by 20% in Patients lacking Adequate SARS-CoV2 Immune Response 17/06/2021 Madeleine Hoecklin A COVID-19 antibody cocktail developed by the US-based company, Regeneron, dramatically reduced the risk of mortality and shortened hospital stays in patients who didn’t naturally produce antibodies against SARS-CoV2 in a recent large-scale trial. Meanwhile, the US government announced that it would invest some US$3.2 billion in developing new forms of antiviral COVID-19 treatments to […] Continue reading -> Latin America Plagued by Slow Vaccine Rollouts, While Region Remains Major COVID Epicenter 17/06/2021 Madeleine Hoecklin & Raisa Santos Despite the global decline in COVID-19 cases by 12% over the last week, countries in Central and South America continue to be epicenters of pandemic, with high mortality rates and insufficient access to vaccines. Over 1.1 million new COVID-19 cases and 31,000 deaths were reported in the Americas over the last week, officials from the […] Continue reading -> Pakistan Introduces Single-Use Syringes as it Battles Fast-Rising HIV/AIDS Infections 16/06/2021 Rahul Basharat Rajput & Muhammed Nadeem Chaudhry ISLAMABAD – Faced with one of the sharpest increases in HIV/AIDS rates in Asia, Pakistan will ban the manufacture and import of conventional syringes from next month, government officials have told Health Policy Watch. The move is in an effort to stem a three-year increase in HIV cases – 39% of which are estimated to […] Continue reading -> Groundbreaking Study: Mosquitoes Armed with Wolbachia Bacteria Reduced Symptomatic Dengue Infections by 77% In Indonesian Trial 16/06/2021 Madeleine Hoecklin In a “groundbreaking” trial conducted in Indonesia, lab-grown mosquitoes infected with Wolbachia bacteria reduced the rate of symptomatic dengue infections by 77%, and hospitalizations by 86%, in communities where the bacteria-armed mosquitoes were released. The three-year study, which was led by the World Mosquito Program, provides compelling evidence for a new method of controlling dengue. […] Continue reading -> Africa’s COVID-19 Vaccination Rollouts Falter as Third Wave Grips Parts of the Continent 15/06/2021 Kerry Cullinan Twenty-two African countries are experiencing a surge in COVID-19 infections, yet the vaccination rollouts on the continent have ground to a halt because of lack of supply. African vaccination figures, as recorded by the Africa Centers for Disease Control and Prevention, are dismal. Apart from the tiny island state of Seychelles, only Morocco’s vaccination rate […] Continue reading -> WHO to Study Social Measures That Keep COVID-19 at Bay – in Case of No Vaccines in Future Pandemics 14/06/2021 Kerry Cullinan The World Health Organization (WHO) is planning to study the public health and social measures that countries have used to keep COVID-19 at bay successfully – in case there is no quick vaccine for the next pandemic. A special working group has been set up with the support of Norway to study these measures, WHO […] Continue reading -> Novavax could make 100 million monthly doses of COVID-19 vaccine by October 14/06/2021 Paul Adepoju Biotech manufacturer Novavax announced on Monday it would be able to manufacture 100 million doses of its two-dose COVID-19 vaccine every month by the end of the third quarter of 2021 and 150 million doses per month by the end of the year – once it has secured regulatory approval for its vaccine. This follows […] Continue reading -> Posts navigation Older postsNewer posts
Latin America Plagued by Slow Vaccine Rollouts, While Region Remains Major COVID Epicenter 17/06/2021 Madeleine Hoecklin & Raisa Santos Despite the global decline in COVID-19 cases by 12% over the last week, countries in Central and South America continue to be epicenters of pandemic, with high mortality rates and insufficient access to vaccines. Over 1.1 million new COVID-19 cases and 31,000 deaths were reported in the Americas over the last week, officials from the […] Continue reading -> Pakistan Introduces Single-Use Syringes as it Battles Fast-Rising HIV/AIDS Infections 16/06/2021 Rahul Basharat Rajput & Muhammed Nadeem Chaudhry ISLAMABAD – Faced with one of the sharpest increases in HIV/AIDS rates in Asia, Pakistan will ban the manufacture and import of conventional syringes from next month, government officials have told Health Policy Watch. The move is in an effort to stem a three-year increase in HIV cases – 39% of which are estimated to […] Continue reading -> Groundbreaking Study: Mosquitoes Armed with Wolbachia Bacteria Reduced Symptomatic Dengue Infections by 77% In Indonesian Trial 16/06/2021 Madeleine Hoecklin In a “groundbreaking” trial conducted in Indonesia, lab-grown mosquitoes infected with Wolbachia bacteria reduced the rate of symptomatic dengue infections by 77%, and hospitalizations by 86%, in communities where the bacteria-armed mosquitoes were released. The three-year study, which was led by the World Mosquito Program, provides compelling evidence for a new method of controlling dengue. […] Continue reading -> Africa’s COVID-19 Vaccination Rollouts Falter as Third Wave Grips Parts of the Continent 15/06/2021 Kerry Cullinan Twenty-two African countries are experiencing a surge in COVID-19 infections, yet the vaccination rollouts on the continent have ground to a halt because of lack of supply. African vaccination figures, as recorded by the Africa Centers for Disease Control and Prevention, are dismal. Apart from the tiny island state of Seychelles, only Morocco’s vaccination rate […] Continue reading -> WHO to Study Social Measures That Keep COVID-19 at Bay – in Case of No Vaccines in Future Pandemics 14/06/2021 Kerry Cullinan The World Health Organization (WHO) is planning to study the public health and social measures that countries have used to keep COVID-19 at bay successfully – in case there is no quick vaccine for the next pandemic. A special working group has been set up with the support of Norway to study these measures, WHO […] Continue reading -> Novavax could make 100 million monthly doses of COVID-19 vaccine by October 14/06/2021 Paul Adepoju Biotech manufacturer Novavax announced on Monday it would be able to manufacture 100 million doses of its two-dose COVID-19 vaccine every month by the end of the third quarter of 2021 and 150 million doses per month by the end of the year – once it has secured regulatory approval for its vaccine. This follows […] Continue reading -> Posts navigation Older postsNewer posts
Pakistan Introduces Single-Use Syringes as it Battles Fast-Rising HIV/AIDS Infections 16/06/2021 Rahul Basharat Rajput & Muhammed Nadeem Chaudhry ISLAMABAD – Faced with one of the sharpest increases in HIV/AIDS rates in Asia, Pakistan will ban the manufacture and import of conventional syringes from next month, government officials have told Health Policy Watch. The move is in an effort to stem a three-year increase in HIV cases – 39% of which are estimated to […] Continue reading -> Groundbreaking Study: Mosquitoes Armed with Wolbachia Bacteria Reduced Symptomatic Dengue Infections by 77% In Indonesian Trial 16/06/2021 Madeleine Hoecklin In a “groundbreaking” trial conducted in Indonesia, lab-grown mosquitoes infected with Wolbachia bacteria reduced the rate of symptomatic dengue infections by 77%, and hospitalizations by 86%, in communities where the bacteria-armed mosquitoes were released. The three-year study, which was led by the World Mosquito Program, provides compelling evidence for a new method of controlling dengue. […] Continue reading -> Africa’s COVID-19 Vaccination Rollouts Falter as Third Wave Grips Parts of the Continent 15/06/2021 Kerry Cullinan Twenty-two African countries are experiencing a surge in COVID-19 infections, yet the vaccination rollouts on the continent have ground to a halt because of lack of supply. African vaccination figures, as recorded by the Africa Centers for Disease Control and Prevention, are dismal. Apart from the tiny island state of Seychelles, only Morocco’s vaccination rate […] Continue reading -> WHO to Study Social Measures That Keep COVID-19 at Bay – in Case of No Vaccines in Future Pandemics 14/06/2021 Kerry Cullinan The World Health Organization (WHO) is planning to study the public health and social measures that countries have used to keep COVID-19 at bay successfully – in case there is no quick vaccine for the next pandemic. A special working group has been set up with the support of Norway to study these measures, WHO […] Continue reading -> Novavax could make 100 million monthly doses of COVID-19 vaccine by October 14/06/2021 Paul Adepoju Biotech manufacturer Novavax announced on Monday it would be able to manufacture 100 million doses of its two-dose COVID-19 vaccine every month by the end of the third quarter of 2021 and 150 million doses per month by the end of the year – once it has secured regulatory approval for its vaccine. This follows […] Continue reading -> Posts navigation Older postsNewer posts
Groundbreaking Study: Mosquitoes Armed with Wolbachia Bacteria Reduced Symptomatic Dengue Infections by 77% In Indonesian Trial 16/06/2021 Madeleine Hoecklin In a “groundbreaking” trial conducted in Indonesia, lab-grown mosquitoes infected with Wolbachia bacteria reduced the rate of symptomatic dengue infections by 77%, and hospitalizations by 86%, in communities where the bacteria-armed mosquitoes were released. The three-year study, which was led by the World Mosquito Program, provides compelling evidence for a new method of controlling dengue. […] Continue reading -> Africa’s COVID-19 Vaccination Rollouts Falter as Third Wave Grips Parts of the Continent 15/06/2021 Kerry Cullinan Twenty-two African countries are experiencing a surge in COVID-19 infections, yet the vaccination rollouts on the continent have ground to a halt because of lack of supply. African vaccination figures, as recorded by the Africa Centers for Disease Control and Prevention, are dismal. Apart from the tiny island state of Seychelles, only Morocco’s vaccination rate […] Continue reading -> WHO to Study Social Measures That Keep COVID-19 at Bay – in Case of No Vaccines in Future Pandemics 14/06/2021 Kerry Cullinan The World Health Organization (WHO) is planning to study the public health and social measures that countries have used to keep COVID-19 at bay successfully – in case there is no quick vaccine for the next pandemic. A special working group has been set up with the support of Norway to study these measures, WHO […] Continue reading -> Novavax could make 100 million monthly doses of COVID-19 vaccine by October 14/06/2021 Paul Adepoju Biotech manufacturer Novavax announced on Monday it would be able to manufacture 100 million doses of its two-dose COVID-19 vaccine every month by the end of the third quarter of 2021 and 150 million doses per month by the end of the year – once it has secured regulatory approval for its vaccine. This follows […] Continue reading -> Posts navigation Older postsNewer posts
Africa’s COVID-19 Vaccination Rollouts Falter as Third Wave Grips Parts of the Continent 15/06/2021 Kerry Cullinan Twenty-two African countries are experiencing a surge in COVID-19 infections, yet the vaccination rollouts on the continent have ground to a halt because of lack of supply. African vaccination figures, as recorded by the Africa Centers for Disease Control and Prevention, are dismal. Apart from the tiny island state of Seychelles, only Morocco’s vaccination rate […] Continue reading -> WHO to Study Social Measures That Keep COVID-19 at Bay – in Case of No Vaccines in Future Pandemics 14/06/2021 Kerry Cullinan The World Health Organization (WHO) is planning to study the public health and social measures that countries have used to keep COVID-19 at bay successfully – in case there is no quick vaccine for the next pandemic. A special working group has been set up with the support of Norway to study these measures, WHO […] Continue reading -> Novavax could make 100 million monthly doses of COVID-19 vaccine by October 14/06/2021 Paul Adepoju Biotech manufacturer Novavax announced on Monday it would be able to manufacture 100 million doses of its two-dose COVID-19 vaccine every month by the end of the third quarter of 2021 and 150 million doses per month by the end of the year – once it has secured regulatory approval for its vaccine. This follows […] Continue reading -> Posts navigation Older postsNewer posts
WHO to Study Social Measures That Keep COVID-19 at Bay – in Case of No Vaccines in Future Pandemics 14/06/2021 Kerry Cullinan The World Health Organization (WHO) is planning to study the public health and social measures that countries have used to keep COVID-19 at bay successfully – in case there is no quick vaccine for the next pandemic. A special working group has been set up with the support of Norway to study these measures, WHO […] Continue reading -> Novavax could make 100 million monthly doses of COVID-19 vaccine by October 14/06/2021 Paul Adepoju Biotech manufacturer Novavax announced on Monday it would be able to manufacture 100 million doses of its two-dose COVID-19 vaccine every month by the end of the third quarter of 2021 and 150 million doses per month by the end of the year – once it has secured regulatory approval for its vaccine. This follows […] Continue reading -> Posts navigation Older postsNewer posts
Novavax could make 100 million monthly doses of COVID-19 vaccine by October 14/06/2021 Paul Adepoju Biotech manufacturer Novavax announced on Monday it would be able to manufacture 100 million doses of its two-dose COVID-19 vaccine every month by the end of the third quarter of 2021 and 150 million doses per month by the end of the year – once it has secured regulatory approval for its vaccine. This follows […] Continue reading -> Posts navigation Older postsNewer posts